// company-profile

Halozyme Therapeutics, Inc.

HALO
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings143Insiders16
// api This Halozyme Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 2 insiders purchased shares versus 1 sale. Buying was led by Snyder Mark Howard.

// 90-day insight

Over the last 90 days, Halozyme Therapeutics, Inc. insiders bought $724K (18 transactions) and sold $189K (1 transaction).

  • Most active insider: Torley Helen with 33 transactions totaling $9.2M.
  • Largest single sale: $1.1M by Torley Helen on Jun 2, 2026.
  • 96% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Halozyme Therapeutics, Inc. as of 2026-03-31

— stable
Total reported AUM
$7.04B
QoQ change
-1.0%
Reporting period
2026-03-31
#1
BlackRock, Inc.
CIK 2012383
$531.8M
8.2M shares
#2
VANGUARD CAPITAL MANAGEMENT LLC
CIK 2100119
$340.7M
5.3M shares
#3
STATE STREET CORP
CIK 93751
$319.1M
4.9M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 12, 2026Snyder Mark HowardHALO
Option Exercise
5,034$0.00$0K
Jun 12, 2026Snyder Mark HowardHALO
Option Exercise
5,034$0.00$0K
Jun 12, 2026Snyder Mark HowardHALO
Tax Withholding
2,715$69.50$189K
Jun 3, 2026Torley HelenHALO
Sale10b5
1,500$67.67$102K
Jun 3, 2026Torley HelenHALO
Sale10b5
2,000$68.74$137K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.